Synopsys jumped 13.4% on August 27 to $464.89. The earnings beat triggered a wave of bullish repositioning across multiple data sets simultaneously.
Why this matters: Three distinct signals — analyst upgrades, options skew, and short covering — all shifted in the same direction within 48 hours of the print. That kind of alignment is rare. It marks a clean break from the pre-earnings narrative, where bears had been trimming cautiously and the stock lagged badly.
Baird's Joe Vruwink upgraded SNPS to Outperform on August 27, raising his target to $560. That was the headline move. But the chorus was wider. Needham reiterated Buy at $580. Benchmark reaffirmed Buy at $570. Rosenblatt held Buy at $575. Five separate analyst actions landed on the same day, all constructive.
The one dissent came from Mizuho, which maintained Outperform but trimmed its target from $600 to $550. Even that is a high target relative to current price.
Consensus now stands at $545 mean target. At Thursday's close of $464.89, that implies roughly 17% upside — a gap that has narrowed sharply from the 42% implied before the print, but still meaningful.
The put/call ratio dropped to 1.13 on August 27. That is 2.57 standard deviations below the 20-day mean of 1.22. It is also the lowest PCR reading in 52 weeks.
This is not a subtle move. Options traders cleared out hedges and added calls at a rate not seen all year. The timing is precise: it coincides with the earnings result and the analyst upgrade wave, not with any prior positioning shift.
Short sellers have continued to exit. SI sits at 2.38% of float, down 15.3% over the past week. That continues a retreat flagged in prior notes. The borrow market is completely unconstrained — availability is effectively unlimited, with roughly 190 million shares available against fewer than 4.4 million borrowed. No squeeze mechanics are in play. The ORTEX short score has fallen to 31.6, near its lowest reading in the recent history.
Institutional holders are broadly adding. UBS added 1.37 million shares in the most recent reporting period. FMR added 594,000. Van Eck added 570,000. T. Rowe Price added 567,000. The top-15 holder list shows net buying across most names.
See the live data behind this article on ORTEX.
Open SNPS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
